[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@hannibalspeaks](/creator/twitter/hannibalspeaks) "That's X million for a mab destined to fail and that had no preclinical data until biotwitter made a fuss. Meanwhile the guy in France who helped create a first in medicine earned a 10th of the US salary" [X Link](https://x.com/hannibalspeaks/status/1977486564763881906) [@hannibalspeaks](/creator/x/hannibalspeaks) 2025-10-12T21:28Z XXX followers, XXX engagements "@LogicalThesis They will need 700-1000 patients over two ph3 trials. FDA may neccistate enrollment of some biologic experienced patients. Going to be expensive they have a dirty rep after $LLY and failed trial mitigating again partnership. May result in dilutive financing" [X Link](https://x.com/hannibalspeaks/status/1979950973754696029) [@hannibalspeaks](/creator/x/hannibalspeaks) 2025-10-19T16:41Z XXX followers, XXX engagements "@LogicalThesis To clarify Nektar has blown up X x billion dollar big pharma partnerships. With LLY and Merck. These were well publiced and if there is a big pharma black list they're on it. Current litigation is a further bad look - fairly or unfairly" [X Link](https://x.com/hannibalspeaks/status/1979952808523682065) [@hannibalspeaks](/creator/x/hannibalspeaks) 2025-10-19T16:48Z XXX followers, XXX engagements "@smiuffy @houndcl @Investorclimber If they screwed retail once how do u know they wont do it on the next readout $ovid @seedy19tron" [X Link](https://x.com/hannibalspeaks/status/1974168365452407112) [@hannibalspeaks](/creator/x/hannibalspeaks) 2025-10-03T17:43Z XXX followers, XXX engagements "Expecting a partial data release from $CRVS with some of cohort X that will be better than a follow-up release with the full data" [X Link](https://x.com/hannibalspeaks/status/1976021065534198054) [@hannibalspeaks](/creator/x/hannibalspeaks) 2025-10-08T20:25Z XXX followers, XXX engagements "Investing is partially about truth it's also about perception. If a small cap produces a signal in obesity it could 10x on perception alone. Same company pre-GLP1 would trade at a discount. Market perception matters" [X Link](https://x.com/hannibalspeaks/status/1976029005829767430) [@hannibalspeaks](/creator/x/hannibalspeaks) 2025-10-08T20:56Z XXX followers, XXX engagements "Those are earnings independent of outcome. No wonder you have $VYNE and so may zombie companies who should return capital" [X Link](https://x.com/hannibalspeaks/status/1977488718807367760) [@hannibalspeaks](/creator/x/hannibalspeaks) 2025-10-12T21:37Z XXX followers, XXX engagements "I'm tired of endless $NKTR chatter; nobody wants to discuss $VTYX or $TERN" [X Link](https://x.com/hannibalspeaks/status/1979675265841422827) [@hannibalspeaks](/creator/x/hannibalspeaks) 2025-10-18T22:25Z XXX followers, 1179 engagements "@Banana_Oncology What's the simplest explanation" [X Link](https://x.com/hannibalspeaks/status/1979959754504999016) [@hannibalspeaks](/creator/x/hannibalspeaks) 2025-10-19T17:16Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@hannibalspeaks
"That's X million for a mab destined to fail and that had no preclinical data until biotwitter made a fuss. Meanwhile the guy in France who helped create a first in medicine earned a 10th of the US salary"
X Link @hannibalspeaks 2025-10-12T21:28Z XXX followers, XXX engagements
"@LogicalThesis They will need 700-1000 patients over two ph3 trials. FDA may neccistate enrollment of some biologic experienced patients. Going to be expensive they have a dirty rep after $LLY and failed trial mitigating again partnership. May result in dilutive financing"
X Link @hannibalspeaks 2025-10-19T16:41Z XXX followers, XXX engagements
"@LogicalThesis To clarify Nektar has blown up X x billion dollar big pharma partnerships. With LLY and Merck. These were well publiced and if there is a big pharma black list they're on it. Current litigation is a further bad look - fairly or unfairly"
X Link @hannibalspeaks 2025-10-19T16:48Z XXX followers, XXX engagements
"@smiuffy @houndcl @Investorclimber If they screwed retail once how do u know they wont do it on the next readout $ovid @seedy19tron"
X Link @hannibalspeaks 2025-10-03T17:43Z XXX followers, XXX engagements
"Expecting a partial data release from $CRVS with some of cohort X that will be better than a follow-up release with the full data"
X Link @hannibalspeaks 2025-10-08T20:25Z XXX followers, XXX engagements
"Investing is partially about truth it's also about perception. If a small cap produces a signal in obesity it could 10x on perception alone. Same company pre-GLP1 would trade at a discount. Market perception matters"
X Link @hannibalspeaks 2025-10-08T20:56Z XXX followers, XXX engagements
"Those are earnings independent of outcome. No wonder you have $VYNE and so may zombie companies who should return capital"
X Link @hannibalspeaks 2025-10-12T21:37Z XXX followers, XXX engagements
"I'm tired of endless $NKTR chatter; nobody wants to discuss $VTYX or $TERN"
X Link @hannibalspeaks 2025-10-18T22:25Z XXX followers, 1179 engagements
"@Banana_Oncology What's the simplest explanation"
X Link @hannibalspeaks 2025-10-19T17:16Z XXX followers, XXX engagements
/creator/twitter::1937207568218345472/posts